vtioВестник трансплантологии и искусственных органовRussian Journal of Transplantology and Artificial Organs1995-1191Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation10.15825/1995-1191-2012-1-114-122vtio-121Research ArticleОбзор литературыLiterature ReviewsОБЗОР МАТЕРИАЛОВ БАНФФ-КОНФЕРЕНЦИИ 2011 ГОДАBANFF-2011 CONFERENCE REPORTТраилинА.В.TrailinA.V.andrei_trailin@ukr.netНиконенкоТ.Н.NikonenkoT.N.НиконенкоА.С.NikonenkoA.S.Государственное учреждение «Запорожская медицинская академия последипломного образования» Министерства здравоохранения УкраиныРоссияSI «Zaporizhzhia Medical Academy of Postgraduate Education of Ministry of Health of Ukraine»Russian FederationГосударственное учреждение «Запорожская медицинская академия последипломного образования» Министерства здравоохранения Украины Запорожский межрегиональный центр трансплантацииРоссияSI «Zaporizhzhia Medical Academy of Postgraduate Education of Ministry of Health of Ukraine» Zaporizhzhia interregional transplantation centreRussian Federation201201052014141114122Copyright © Траилин А., Никоненко Т., Никоненко А., 20122012Траилин А., Никоненко Т., Никоненко А.Trailin A., Nikonenko T., Nikonenko A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.transpl.ru/vtio/article/view/121

В июне 2011 года в пригороде Парижа состоялась 11-я Банфф-конференция, посвященная актуальным во- просам патологии аллотрансплантатов солидных органов. Были заслушаны доклады созданных на преды- дущей конференции рабочих групп по оценке гломерулярных поражений, способам оценки интерстици- ального фиброза, изучению роли изолированного интимального артериита, оценке полиомавирусной не- фропатии, молекулярной патологии трансплантатов и обеспечению качества иммуногистохимических ис- следований. Главными темами обсуждения были: антитело-опосредованное отторжение, ведение сенси- билизированных пациентов, подходы к диагностике отторжения трансплантатов на основе методов гено- мики и протеомики, роль протокольных биопсий. Поступили предложения пересмотреть способы оценки полиомавирусной нефропатии, гломерулита, трансплантационной гломерулопатии. Термин «эпителиально- мезенхимальное превращение» был признан неудачным и нуждающимся в замене. 

The 11th Banff Conference of solid organs allografts pathology was held in a suburb of Paris from June 6 to 10. Papers were presented by created at the previous conference working groups on the following areas: isolated v-lesion, fibrosis scoring, glomerular lesions, molecular pathology, polyomavirus nephropathy and quality assurance of immunohis-tochemical procedures. The main topics of discussion were antibody-mediated rejection, management of sensitized patients, the approach to the diagnosis of transplant rejection by the methods of genomics and proteomics, and the role of protocol biopsies. There were suggestions to reconsider how to assess polyomavirus nephropathy, glomerulitis, transplant glomerulopathy. Term «epithelial-mesenchymal transition» was considered inappropriate and need to be replaced. 

Банффтрансплантацияотторжение аллотрансплантатагистологические изменениягеномные маркеры.Banfftransplantationallograft rejectionhistological lesionsgenomic markers.ReferencesТраилин А.В., Никоненко Т.Н., Остапенко Т.И. и др. Исходное состояние донорской почки и риск развития отсроченной и замедленной функции почечного аллотрансплантата // Вестник трансплантологии и искусственных органов. 2008. Т. 41. No 3. С. 13–18.Траилин А.В., Никоненко Т.Н., Остапенко Т.И. и др. Исходное состояние донорской почки и риск развития отсроченной и замедленной функции почечного аллотрансплантата // Вестник трансплантологии и искусственных органов. 2008. Т. 41. No 3. С. 13–18.Траилин А.В., Никоненко Т.Н., Остапенко Т.И. и др. Морфологические и иммуногистохимические проявления различных форм острого отторжения почечного аллотрансплантата // Вестник трансплан-Траилин А.В., Никоненко Т.Н., Остапенко Т.И. и др. Морфологические и иммуногистохимические проявления различных форм острого отторжения почечного аллотрансплантата // Вестник трансплан-тологии и искусственных органов. 2009. Т. 11. No 2.тологии и искусственных органов. 2009. Т. 11. No 2.С. 29–36.С. 29–36.Траілін А.В., Никоненко Т.М. Спосіб визначення ступеня хронічної недостатності ниркового алотрансплантату Пат. 46208 Україна, МПК G01N 33/50. Заявник і патентовласник Запорізька медична академія післядипломної освіти. – No u 2009 06739. Заявл. 26.06.09. Опубл. 10.12.09. Бюл. No 23.Траілін А.В., Никоненко Т.М. Спосіб визначення ступеня хронічної недостатності ниркового алотрансплантату Пат. 46208 Україна, МПК G01N 33/50. Заявник і патентовласник Запорізька медична академія післядипломної освіти. – No u 2009 06739. Заявл. 26.06.09. Опубл. 10.12.09. Бюл. No 23.Траилин А.В. Оценка концентрации в сыворотке растворимого CD30 в диагностике ранней дисфункции почечного аллотрансплантата // Клінічна хірургія. 2009. No 10. С. 44–46.Траилин А.В. Оценка концентрации в сыворотке растворимого CD30 в диагностике ранней дисфункции почечного аллотрансплантата // Клінічна хірургія. 2009. No 10. С. 44–46.Траилин А.В., Никоненко А.С., Никоненко Т.Н. и др. Оценка риска развития острой реакции отторжения почечного аллотрансплантата путем определения сывороточной концентрации IP10 // Медицина сегодня и завтра. 2011. No 1–2. С. 263–265.Траилин А.В., Никоненко А.С., Никоненко Т.Н. и др. Оценка риска развития острой реакции отторжения почечного аллотрансплантата путем определения сывороточной концентрации IP10 // Медицина сегодня и завтра. 2011. No 1–2. С. 263–265.Anglicheau D., Loupy A., Lefaucheur C. et al. A simple clinico-histopathological composite scoring system is highly predictive of graft outcomes in marginal donors // Am. J. Transplant. 2008. Vol. 8. P. 2325–2334.Anglicheau D., Loupy A., Lefaucheur C. et al. A simple clinico-histopathological composite scoring system is highly predictive of graft outcomes in marginal donors // Am. J. Transplant. 2008. Vol. 8. P. 2325–2334.Batal I., Lunz J.G. 3rd, Aggarwal N. et al. A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies // Am. J. Transplant. 2010. Vol. 10. P. 2442–2452.Batal I., Lunz J.G. 3rd, Aggarwal N. et al. A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies // Am. J. Transplant. 2010. Vol. 10. P. 2442–2452.Batal I., Azzi J., El-Haddad N. et al. Immunohistochemical markers of tissue injury in biopsies with transplant glomerulitis. Hum Pathol. 2011.Batal I., Azzi J., El-Haddad N. et al. Immunohistochemical markers of tissue injury in biopsies with transplant glomerulitis. Hum Pathol. 2011.Bray R.A., Nickerson P.W., Kerman R.H., Gebel H.M. Evolution of HLA antibody detection: technology emulating biology // Immunol. Res. 2004. Vol. 29. P. 41–54.Bray R.A., Nickerson P.W., Kerman R.H., Gebel H.M. Evolution of HLA antibody detection: technology emulating biology // Immunol. Res. 2004. Vol. 29. P. 41–54.Bray R.A., Tarsitani C., Gebel H.M., Lee J.H. Clinical cytometry and progress in HLA antibody detection // Methods Cell. Biol. 2011. Vol. 103. P. 285–310.Bray R.A., Tarsitani C., Gebel H.M., Lee J.H. Clinical cytometry and progress in HLA antibody detection // Methods Cell. Biol. 2011. Vol. 103. P. 285–310.De Serres S.A., Vadivel N., Mfarrej B.G. et al. Monocyte-secreted inflammatory cytokines are associated with transplant glomerulopathy in renal allograft recipients // Transplantation. 2011. Vol. 15. P. 552–559.De Serres S.A., Vadivel N., Mfarrej B.G. et al. Monocyte-secreted inflammatory cytokines are associated with transplant glomerulopathy in renal allograft recipients // Transplantation. 2011. Vol. 15. P. 552–559.Drachenberg C.B., Papadimitriou J.C., Hirsch H.H. et al. Histological Patterns of Polyomavirus Nephropathy: Correlation with Graft Outcome and Viral Load // Am. J. Transplant. 2004. Vol. 4. P. 2082–2092.Drachenberg C.B., Papadimitriou J.C., Hirsch H.H. et al. Histological Patterns of Polyomavirus Nephropathy: Correlation with Graft Outcome and Viral Load // Am. J. Transplant. 2004. Vol. 4. P. 2082–2092.Einecke G., Broderick G., Sis B., Halloran P.F. Early Loss of Renal Transcripts in Kidney Allografts: Relationship to the Development of Histologic Lesions and Alloimmune Effector Mechanisms // Am. J. Transplant. 2007. Vol. 7. P. 1121–1130.Einecke G., Broderick G., Sis B., Halloran P.F. Early Loss of Renal Transcripts in Kidney Allografts: Relationship to the Development of Histologic Lesions and Alloimmune Effector Mechanisms // Am. J. Transplant. 2007. Vol. 7. P. 1121–1130.Einecke G., Reeve J., Sis B. et al. A molecular classifier for predicting future graft loss in late kidney transplant biopsies // J. Clin. Invest. 2010. Vol. 120. P. 1862–1872.Einecke G., Reeve J., Sis B. et al. A molecular classifier for predicting future graft loss in late kidney transplant biopsies // J. Clin. Invest. 2010. Vol. 120. P. 1862–1872.Farris A.B., Adams C.D., Brousaides N. et al. Morphometric and visual evaluation of fibrosis in renal biopsies // J. Am. Soc. Nephrol. 2011. Vol. 22. P. 176–186.Farris A.B., Adams C.D., Brousaides N. et al. Morphometric and visual evaluation of fibrosis in renal biopsies // J. Am. Soc. Nephrol. 2011. Vol. 22. P. 176–186.Frisch St.M. Disruption of epithelial cell-matrix interactions induces apoptosis // J. Cell Biol. 1994. Vol. 124. P. 619–626.Frisch St.M. Disruption of epithelial cell-matrix interactions induces apoptosis // J. Cell Biol. 1994. Vol. 124. P. 619–626.Gloor J., Stegall M.D. Sensitized renal transplant recipients: current protocols and future directions // Nat. Rev. Nephrol. 2010. Vol. 6. P. 297–306.Gloor J., Stegall M.D. Sensitized renal transplant recipients: current protocols and future directions // Nat. Rev. Nephrol. 2010. Vol. 6. P. 297–306.Halloran P.F., de Freitas D.G., Einecke G. et al. An integrated view of molecular changes, histopathology and outcomes in kidney transplants // Am. J. Transplant. 2010. Vol. 10. P. 2223–2230.Halloran P.F., de Freitas D.G., Einecke G. et al. An integrated view of molecular changes, histopathology and outcomes in kidney transplants // Am. J. Transplant. 2010. Vol. 10. P. 2223–2230.19. Halloran P.F., de Freitas D.G., Einecke G. et al. The molecular phenotype of kidney transplants // Am. J. Transplant. 2010. Vol. 10. P. 2215–2222.19. Halloran P.F., de Freitas D.G., Einecke G. et al. The molecular phenotype of kidney transplants // Am. J. Transplant. 2010. Vol. 10. P. 2215–2222.Hertig A., Anglicheau D., Verine J. et al. Early Epithelial Phenotypic Changes Predict Graft Fibrosis // J. Am. Soc. Nephrol. 2008. Vol. 19. P. 1584–1591.Hertig A., Anglicheau D., Verine J. et al. Early Epithelial Phenotypic Changes Predict Graft Fibrosis // J. Am. Soc. Nephrol. 2008. Vol. 19. P. 1584–1591.Hidalgo L.G., Campbell P.M., Sis B. et al. De Novo Donor-Specific Antibody at the Time of Kidney Transplant Biopsy Associates with Microvascular Pathology and Late Graft Failure // Am. J. Transplant. 2009. Vol. 9. P. 2532–2541. rejection // Expert Opin. Investig. Drugs. 2011. Vol. 20. P. 1535–1542.Hidalgo L.G., Campbell P.M., Sis B. et al. De Novo Donor-Specific Antibody at the Time of Kidney Transplant Biopsy Associates with Microvascular Pathology and Late Graft Failure // Am. J. Transplant. 2009. Vol. 9. P. 2532–2541. rejection // Expert Opin. Investig. Drugs. 2011. Vol. 20. P. 1535–1542.Servais A., Meas-Yedid V., Noël L.H. et al. InterstitialServais A., Meas-Yedid V., Noël L.H. et al. InterstitialFibrosis Evolution on Early Sequential Screening Renal Allograft Biopsies Using Quantitative Image Analysis // Am. J. Transplant. 2011. Vol. 11. P. 1456–1463.Fibrosis Evolution on Early Sequential Screening Renal Allograft Biopsies Using Quantitative Image Analysis // Am. J. Transplant. 2011. Vol. 11. P. 1456–1463.Schaub S., Nickerson P., Rush D. et al. Urinary CXCL9 and CXCL10 levels correlate with the extent of subclinical tubulitis // Am. J. Transplant. 2009. Vol. 9. P. 1347– 1353.Schaub S., Nickerson P., Rush D. et al. Urinary CXCL9 and CXCL10 levels correlate with the extent of subclinical tubulitis // Am. J. Transplant. 2009. Vol. 9. P. 1347– 1353.Singh H.K., Andreoni K.A., Madden V. et al. Presence of Urinary Haufen Accurately Predicts Polyomavirus Nephropathy // J. Am. Soc. Nephrol. 2009. Vol. 20. P. 416Singh H.K., Andreoni K.A., Madden V. et al. Presence of Urinary Haufen Accurately Predicts Polyomavirus Nephropathy // J. Am. Soc. Nephrol. 2009. Vol. 20. P. 416Hidalgo L.G., Sis B., Sellares J. et al. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in 427. antibody-mediated rejection // Am. J. Transplant. 2010. Vol. 10. P. 1812–1822.Hidalgo L.G., Sis B., Sellares J. et al. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in 427. antibody-mediated rejection // Am. J. Transplant. 2010. Vol. 10. P. 1812–1822.Hill G.S., Nochy D., Bruneval P. et al. Donor-Specific Antibodies Accelerate Arteriosclerosis after Kidney Transplantation // J. Am. Soc. Nephrol. 2011. Vol. 22. P. 975–983.Hill G.S., Nochy D., Bruneval P. et al. Donor-Specific Antibodies Accelerate Arteriosclerosis after Kidney Transplantation // J. Am. Soc. Nephrol. 2011. Vol. 22. P. 975–983.Ibernón M., Gomá M., Moreso F. et al. Subclinical rejection impairs glomerular adaptation after renal transplantation // Kidney Int. 2006. Vol. 70. P. 557–561.Ibernón M., Gomá M., Moreso F. et al. Subclinical rejection impairs glomerular adaptation after renal transplantation // Kidney Int. 2006. Vol. 70. P. 557–561.Jordan S.C., Reinsmoen N., Peng A. et al. Advances in diagnosing and managing antibody-mediated rejection // Pediatr. Nephrol. 2010. Vol. 25. P. 2035–2048.Jordan S.C., Reinsmoen N., Peng A. et al. Advances in diagnosing and managing antibody-mediated rejection // Pediatr. Nephrol. 2010. Vol. 25. P. 2035–2048.Kalluri R. and Weinberg R.A. The basics of epithelialmesenchymal transition // J. Clin. Invest. 2009. Vol. 119. P. 1420–1428.Kalluri R. and Weinberg R.A. The basics of epithelialmesenchymal transition // J. Clin. Invest. 2009. Vol. 119. P. 1420–1428.Kayler L.K., Mohanka R., Basu A. et al. Correlation of histologic findings on preimplant biopsy with kidney graft survival // Transpl. Int. 2008. Vol. 21. P. 892–908.Kayler L.K., Mohanka R., Basu A. et al. Correlation of histologic findings on preimplant biopsy with kidney graft survival // Transpl. Int. 2008. Vol. 21. P. 892–908.Lefaucheur C., Loupy A., Hill G.S. et al. Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation // J. Am. Soc. Nephrol. 2010. Vol. 21. P. 1398–1406.Lefaucheur C., Loupy A., Hill G.S. et al. Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation // J. Am. Soc. Nephrol. 2010. Vol. 21. P. 1398–1406.Le Hir M., Hegyi I., Cueni-Loffing D. et al. Characterization of renal interstitial fibroblast-specific protein 1/ S100A4-positive cells in healthy and inflamed rodent kid- neys // Histochem. Cell. Biol. 2005. Vol. 123. P. 335–346.Le Hir M., Hegyi I., Cueni-Loffing D. et al. Characterization of renal interstitial fibroblast-specific protein 1/ S100A4-positive cells in healthy and inflamed rodent kid- neys // Histochem. Cell. Biol. 2005. Vol. 123. P. 335–346.Le Texier L., Thebault P., Lavault A. et al. Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile // Am. J. Transplant. 2011. Vol. 11. P. 429–438.Le Texier L., Thebault P., Lavault A. et al. Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile // Am. J. Transplant. 2011. Vol. 11. P. 429–438.Loupy A., Suberbielle-Boissel C., Hill G.S. et al. Outcome of Subclinical Antibody-Mediated Rejection in Kidney Transplant Recipients with Preformed Donor- Specific Antibodies // Am. J. Transplant. 2009. Vol. 9. P. 2561–2570.Loupy A., Suberbielle-Boissel C., Hill G.S. et al. Outcome of Subclinical Antibody-Mediated Rejection in Kidney Transplant Recipients with Preformed Donor- Specific Antibodies // Am. J. Transplant. 2009. Vol. 9. P. 2561–2570.Mengel M., Gwinner W., Schwarz A. et al. Infiltrates in protocol biopsies from renal allografts // Am. J. Transplant. 2007. V. 7. P. 356–365.Mengel M., Gwinner W., Schwarz A. et al. Infiltrates in protocol biopsies from renal allografts // Am. J. Transplant. 2007. V. 7. P. 356–365.Mengel M., Chang J., Kayser D. et al. The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course // Am. J. Transplant. 2011. Vol. 11. P. 708–718.Mengel M., Chang J., Kayser D. et al. The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course // Am. J. Transplant. 2011. Vol. 11. P. 708–718.Moreso F., Ibernon M., Gomà M. et al. Subclinical Rejection Associated with Chronic Allograft Nephropathy in Protocol Biopsies as a Risk Factor for Late Graft Loss // Am. J. Transplant. 2006. Vol. 6. P. 747–752.Moreso F., Ibernon M., Gomà M. et al. Subclinical Rejection Associated with Chronic Allograft Nephropathy in Protocol Biopsies as a Risk Factor for Late Graft Loss // Am. J. Transplant. 2006. Vol. 6. P. 747–752.Sadaka B., Alloway R.R., Woodle E.S. Clinical and investigational use of proteasome inhibitors for transplantSadaka B., Alloway R.R., Woodle E.S. Clinical and investigational use of proteasome inhibitors for transplantSis B., Mengel M., Haas M. et al. Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Imple- mentation of Banff Working Groups // Am. J. Transplant. 2010. Vol. 10. P. 464–471.Sis B., Mengel M., Haas M. et al. Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Imple- mentation of Banff Working Groups // Am. J. Transplant. 2010. Vol. 10. P. 464–471.Sis B., Einecke G., Chang J. et al. Cluster analysis of lesions in nonselected kidney transplant biopsies: microcirculation changes, tubulointerstitial inflammation and scarring // Am. J. Transplant. 2010. Vol. 10. P. 421–430.Sis B., Einecke G., Chang J. et al. Cluster analysis of lesions in nonselected kidney transplant biopsies: microcirculation changes, tubulointerstitial inflammation and scarring // Am. J. Transplant. 2010. Vol. 10. P. 421–430.Stegall M.D., Park W.D., Larson T.S. et al. The histology of solitary renal allografts at 1 and 5 years after transplantation // Am. J. Transplant. 2011. Vol. 11. P. 698–707.Stegall M.D., Park W.D., Larson T.S. et al. The histology of solitary renal allografts at 1 and 5 years after transplantation // Am. J. Transplant. 2011. Vol. 11. P. 698–707.Stegall M.D., Diwan T., Raghavaiah S. et al. Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients // Am. J. Transplant. 2011. Vol. 11. P. 2405–2413.Stegall M.D., Diwan T., Raghavaiah S. et al. Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients // Am. J. Transplant. 2011. Vol. 11. P. 2405–2413.Van Ham S.M., Heutinck K.M., Jorritsma T. et al. Urinary granzyme A mRNA is a biomarker to diagnose sub- clinical and acute cellular rejection in kidney transplant recipients // Kidney Int. 2010. Vol. 78. P. 1033–1040.Van Ham S.M., Heutinck K.M., Jorritsma T. et al. Urinary granzyme A mRNA is a biomarker to diagnose sub- clinical and acute cellular rejection in kidney transplant recipients // Kidney Int. 2010. Vol. 78. P. 1033–1040.Vongwiwatana A., Tasanarong A., Rayner D.C. et al. Epithelial to mesenchymal transition during late deterioration of human kidney transplants: the role of tubular cells in fibrogenesis // Am. J. Transplant. 2005. Vol. 5. P. 1367–1374.Vongwiwatana A., Tasanarong A., Rayner D.C. et al. Epithelial to mesenchymal transition during late deterioration of human kidney transplants: the role of tubular cells in fibrogenesis // Am. J. Transplant. 2005. Vol. 5. P. 1367–1374.Walsh R.C., Everly J.J., Brailey P. et al. Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection // Transplantation. 2010. Vol. 89. P. 277–284.Walsh R.C., Everly J.J., Brailey P. et al. Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection // Transplantation. 2010. Vol. 89. P. 277–284.Walsh R.C., Brailey P., Girnita A. et al. Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition // Transplantation. 2011. Vol. 91. P. 1218–1226.Walsh R.C., Brailey P., Girnita A. et al. Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition // Transplantation. 2011. Vol. 91. P. 1218–1226.Wang H., Rollins S.A., Gao Z. et al. Complement inhibition with an anti-C5 monoclonal antibody prevents hyperacute rejection in a xenograft heart transplantation model // Transplantation. 1999. Vol. 68. P. 1643– 1651.Wang H., Rollins S.A., Gao Z. et al. Complement inhibition with an anti-C5 monoclonal antibody prevents hyperacute rejection in a xenograft heart transplantation model // Transplantation. 1999. Vol. 68. P. 1643– 1651.Ward W.W. Biochemical and physical properties of green fluorescent protein // Methods Biochem. Anal. 2006. Vol. 47. P. 39–65.Ward W.W. Biochemical and physical properties of green fluorescent protein // Methods Biochem. Anal. 2006. Vol. 47. P. 39–65.Yang J., Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis // Am. J. Pathol. 2001. Vol. 159. P. 1465–1475.Yang J., Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis // Am. J. Pathol. 2001. Vol. 159. P. 1465–1475.Yushkov Y., Dikman S., Alvarez-Casas J. et al. Optimized technique in needle biopsy protocol shown to be of greater sensitivity and accuracy compared to wedge biopsy // Transplant Proc. 2010. Vol. 42. P. 2493–2497.Yushkov Y., Dikman S., Alvarez-Casas J. et al. Optimized technique in needle biopsy protocol shown to be of greater sensitivity and accuracy compared to wedge biopsy // Transplant Proc. 2010. Vol. 42. P. 2493–2497.

The authors declare that there are no conflicts of interest present.